Early Human Insight means generating human data well in advance of clinical studies. This redefines the concept of “first in human.” The benefits include:
Identify and focus resources on the most valuable compounds
Calibrate predictivity of other in vitro or in vivo models
Assess efficacy/safety on authentic human targets
Generate quantitatively reliable data on potency and selectivity in humans
Avoid translational challenges frequently encountered with animal models